enGene announces poster presentation containing interim Phase 1 clinical trial data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium

/PRNewswire/ - enGene Inc., a clinical-stage biotechnology company pioneering non-viral gene therapies for local administration to mucosal tissues enabled by...

Related Keywords

Boston ,Massachusetts ,United States ,American ,Gary Steinberg ,Jason Hanson ,Langone Health ,American Society Of Clinical Oncology ,Department Of Urology ,Dgene Inc ,Goldstein Urology Bladder Cancer Program ,Perlmutter Cancer Center ,Interim Phase ,American Society ,Clinical Oncology ,Genitourinary Cancers Symposium ,Prostate Cancer ,Mengene ,